Thoratec Schedules Fourth Quarter Conference Call, Webcast

          Thoratec Schedules Fourth Quarter Conference Call, Webcast

PR Newswire

PLEASANTON, Calif., Jan. 23, 2014

PLEASANTON, Calif., Jan. 23, 2014 /PRNewswire/ --Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, today announced that it
will report its operating results for the fourth quarter of fiscal year 2013
on Tuesday, February 4.

The company will hold a conference call to discuss its financial results and
operating activities, open to all interested parties, at 1:30 p.m., Pacific
Standard Time (4:30 p.m., Eastern Standard Time), Tuesday, February 4, hosted
by Gary F. Burbach, President and Chief Executive Officer, and Taylor C.
Harris, Vice President and Chief Financial Officer.

The teleconference can be accessed by calling (913) 312-1456, passcode
1086255. Please dial in 10-15 minutes prior to the beginning of the call. The
webcast will be available on the Internet at
http://www.media-server.com/m/acs/7fced1c2310f7bb3d88bf9c802a85737, or
http://www.thoratec.com.

A replay of the conference call will be available through Tuesday, February
11, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode
1086255.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered
trademarks of Thoratec Corporation. CentriMag and PediMag are registered
trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec
Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Neil Meyer, Director of Investor Relations, Thoratec Corporation,
(925) 738-0029